97 reports

  • TUBERCULOSIS, PNEUMONIA, MRSA, SEPSIS, GLOBAL, PIPELINES BY MOLECULAR TARGET, 2017
  • 4.2.2 MRSA

Acquired Antibiotic Resistance Genes: An Overview.

  • Anti-Infective
  • Antibiotic Resistance
  • Therapy
  • World
  • Deals & Alliance
  • DEVELOPMENT OF ANTIBIOTIC RESISTANCE
  • SPREAD OF ANTIBIOTIC RESISTANCE

About Antibiotics An antibiotic is a chemical compound that kills or slows down the growth of any disease-causing microorganisms such as bacteria, parasite, and fungi but is not effective against viruses and prions. The term "antibiotic" was originally coined to refer to any compound of microbial origin that is antagonistic to...

  • Antibiotic Resistance
  • Allergan plc
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Rising government initiatives to combat antibiotic resistance
  • RISING GOVERNMENT INITIATIVES TO COMBAT ANTIBIOTIC RESISTANCE

About Gonorrhea Therapeutics Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep...

  • Antibiotic Resistance
  • World
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • immense threat from antibiotic resistance posed on global public health.

Impetigo - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Pipeline Review, H1 2018, provides an overview of the Impetigo (Infectious Disease) pipeline landscape. Impetigo is a highly contagious skin condition....

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • Product Initiative
  • Foamix Ltd.
  • ALGORITHM - BACTERIAL ANTIBIOTIC RESISTANCE
  • ALGORITHM - BACTERIAL ANTIBIOTIC RESISTANCE PRODUCT OVERVIEW

Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs).The company’s clinical laboratory services include high resolution microbial sequence analysis, swift detection and analysis...

  • Antibiotic Resistance
  • Healthcare
  • Hospital
  • United States
  • OpGen, Inc.
  • APR 12, 2017: OPGEN TO PRESENT ANTIBIOTIC RESISTANCE PREDICTION DATA AT 25TH EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (ECCMID)
  • EQUITY OFFERING

Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs).The company’s clinical laboratory services include high resolution microbial sequence analysis, swift detection and analysis...

  • Antibiotic Resistance
  • Healthcare
  • Medical Equipment
  • United States
  • OpGen, Inc.
  • ANTIBIOTIC RESISTANCE PANEL
  • SAGE ULTRAFAST ANTIBIOTIC RESISTANCE TEST

Summary GNA Biosolutions GmbH (GNAB) is an assays and instruments development company that develops assays and instruments for ultra-fast molecular pathogen detection of biomolecules through its technology.The company also develops rapid diagnostic DNA-based laser-heated nanoparticles. It uses PCR (Polymerase Chain...

  • Antibiotic Resistance
  • In Vitro Diagnostics
  • World
  • Company
  • Product Initiative
  • SELECTED COMPANIES MARKETING PCR/NAAT SYNDROMIC TESTS/PANELS FOR INFECTIOUS DISEASES
  • HIV

The PCR testing market, which includes other NAAT technologies, is a large and diverse market. This market consists of three segments: the life science (research) NAAT market, the clinical NAAT market, and an "other" segment that includes forensics, environmental monitoring, veterinary, and other applications that do not involve...

  • Antibiotic Resistance
  • Blood Supply
  • United States
  • World
  • Biocartis S.A.
  • Emergence of antibiotic resistance
  • MARKET CHALLENGES

About Microbiology Laboratory Supplies Microbiology laboratory supplies include consumables that are repeatedly and periodically used to test for microbial contamination in products, and to ensure that they are free from this kind of contamination, which can arise at any stage of the product development life cycle. Technavio’s...

  • Antibiotic Resistance
  • Danaher Corporation
  • Merck & Co., Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • OPGEN RAISES USD10 MILLION IN PUBLIC OFFERING OF UNITS
  • EQUITY OFFERING

GlobalData OpGen Inc reported one pharmaceuticals & healthcare deal worth $## million in YTD 2018.

  • Antibiotic Resistance
  • Healthcare
  • United States
  • Company
  • OpGen, Inc.
  • 12.3.4 Antibiotic Resistance Patterns
  • ILLUSTRATION DEPICTING THE KEY MECHANISMS OF ANTIBIOTIC RESISTANCE OBSERVED IN GRAM-

PharmaPoint: Healthcare-Associated Gram-Negative Infections - Global Drug Forecast and Market Analysis to 2026 Summary Bacterial infections represent a frequent occurrence in humans. Fortunately, a majority of these infections are successfully eliminated by the native and adaptive immune system. The majority of remaining...

  • Antibiotic Resistance
  • Achaogen, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • The Medicines Company
  • APR 27, 2015: TAXIS PHARMACEUTICALS DEMONSTRATES CLINICAL POTENTIAL OF TXA709 IN COMBATING ANTIBIOTIC RESISTANCE
  • JUN 05, 2015: TAXIS PHARMACEUTICALS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING POTENTIAL VIABILITY OF TXA709 IN COMBATING ANTIBIOTIC RESISTANCE

Cell Division Protein FtsZ (ftsz) - Pipeline Review, H1 2018 Summary According to the recently published report ’Cell Division Protein FtsZ (ftsz) - Pipeline Review, H1 2018’; Cell Division Protein FtsZ (ftsz) pipeline Target constitutes close to 9 molecules. Out of which approximately 2 molecules...

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • 7.3.3 FRANCE
  • 8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS

France was one of the first nations in Europe to implement a program against antibiotic resistance in early 2000.

  • Antibiotic Resistance
  • North America
  • United States
  • World
  • Forecast
  • JUN 05, 2015: TAXIS PHARMACEUTICALS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING POTENTIAL VIABILITY OF TXA709 IN COMBATING ANTIBIOTIC RESISTANCE
  • APR 27, 2015: TAXIS PHARMACEUTICALS DEMONSTRATES CLINICAL POTENTIAL OF TXA709 IN COMBATING ANTIBIOTIC RESISTANCE

Cell Division Protein FtsZ (ftsz) - Pipeline Review, H2 2017 Summary Cell Division Protein FtsZ (ftsz) - FtsZ is a protein encoded by the ftsZ gene. It is essential cell division protein that forms a contractile ring structure at the future cell division site. The regulation of the ring assembly...

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • 4.6.9 CONCLUSION
  • 2.7.2 MRSA

Antibiotic resistance genes have allowed bacteria to become capable of developing resistance to antibiotics through several mechanisms.

  • Antibiotic Resistance
  • World
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

Q. ##.

  • Antibiotic Resistance
  • North America
  • United States
  • Forecast
  • Thermo Fisher Scientific, Inc.
  • MOUNTING THREAT OF MICROBIAL ANTIBIOTIC RESISTANCE
  • MOUNTING THREAT OF MICROBIAL ANTIBIOTIC RESISTANCE

World Market for Infectious Disease Tests provides detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening and subsegments within. POC and home testing markets for infectious disease are also...

  • Antibiotic Resistance
  • Alere Inc.
  • Cepheid
  • Hologic, Inc.
  • Roche Group
  • OPGEN INC - OPPORTUNITIES
  • MAR 13, 2018: OPGEN ANNOUNCES COLLABORATOR IN VERIFICATION STUDY FOR ACUITAS TEST

Each unit included one twenty-fifth of a share of common stock and one common warrant to purchase one twenty-fifth of a share of common stock at an exercise price of $##. ## per share.

  • Antibiotic Resistance
  • Healthcare
  • United States
  • Company Financials
  • OpGen, Inc.

This approach is less susceptible to development of antibiotic resistance, can be used both therapeutically and prophylactically.

  • Antibiotic Resistance
  • Monoclonal Antibody
  • United States
  • World
  • Product Initiative
  • Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Product Development Milestones

Announcement comes at a critical time for the antibiotic industry, in light of the latest report from the O' Neill Review on Antibiotic Resistance (##th May 2015), which highlighted the human and financial costs that society faces as a result of antibiotic resistant infections,

  • Antibiotic Resistance
  • Hospital
  • World
  • Product Initiative
  • MGB Biopharma Limited
  • Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Product Development Milestones

" The figures highlighted in Jim O' Neill' s report - and in particular the potential human cost of not addressing antibiotic resistance - are significant.

  • Antibiotic Resistance
  • Hospital
  • World
  • Product Initiative
  • MGB Biopharma Limited
  • ATLAS IO SYSTEM - BACTERIAL IDENTIFICATION AND ANTIBIOTIC RESISTANCE
  • ATLAS IO SYSTEM - BACTERIAL IDENTIFICATION AND ANTIBIOTIC RESISTANCE - PRODUCT STATUS

Summary Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposable cartridge system, which...

  • Antibiotic Resistance
  • Sexually Transmitted Disease
  • United Kingdom
  • United States
  • GlobalData's company

This approach is less susceptible to development of antibiotic resistance, can be used both therapeutically and prophylactically.

  • Antibiotic Resistance
  • Infectious Disease
  • United States
  • World
  • Product Initiative
  • Jan 18, 2017: Recce's lead compound reduces illness in mice infected by resistant E. coil bacteria

It was developed in response to growing rates of antibiotic resistance in bacteria such as E.

  • Antibiotic Resistance
  • Therapy
  • United States
  • Product Initiative
  • Melinta Therapeutics, Inc.
  • immense threat from antibiotic resistance posed on global public health.
  • JUL 13, 2016: UNMC RESEARCHER SECURES $2.25 MILLION GRANT TO FIGHT ANTIBIOTIC RESISTANCE

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018, provides an overview of the...

  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • Melinta Therapeutics, Inc.
  • Research and Development Brief
  • CF-301 - DRUG PROFILE

Pseudomonas aeruginosa Infections - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Pseudomonas aeruginosa Infections - Pipeline Review, H1 2018, provides an overview of the Pseudomonas aeruginosa Infections (Infectious Disease)...

  • Antibiotic Resistance
  • Therapy
  • United States
  • Company
  • Product Initiative
  • ANTIBIOTIC RESISTANCE
  • ANTIBIOTIC RESISTANCE PREVENTION

Abstract • Antibiotics are drugs used to treat infections that are caused by bacteria. • The introduction of antibiotics is recognized as one of the most transformative events in medicine. • Prior to the introduction of the first antibiotics in the 1930s and 1940s, bacterial infections were often fatal, and invasive surgery...

  • Antibiotic Resistance
  • United States
  • Cempra, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SEP 06, 2017: AMPLIPHI BIOSCIENCES ANNOUNCES RECEIPT OF $2.0 MILLION R&D TAX INCENTIVE
  • AMPLIPHI BIOSCIENCES CORP - OPPORTUNITIES

Antibiotic resistance is a serious and growing phenomenon in contemporary medicine and has emerged as one of the eminent public health concerns of the ##st century.

  • Antibiotic Resistance
  • Therapy
  • United States
  • Company Financials
  • AmpliPhi Biosciences Corporation
  • SMALL MOLECULE TO INHIBIT DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA AND HIV INTEGRASE FOR HIV AND TUBERCULOSIS - DRUG PROFILE
  • FEATURED NEWS & PRESS RELEASES

SIRTURO also represents an important tool in support of global public health efforts to tackle bacterial resistance to antibiotics.

  • Antibiotic Resistance
  • Tuberculosis
  • Vaccine
  • World
  • TB Drug Development, Inc.
  • SYNTIRON LLC
  • SMALL MOLECULES TO INHIBIT LETHAL FACTOR FOR ANTHRAX AND CYSTIC FIBROSIS - DRUG PROFILE

ANTHRAX - PIPELINE BY SOLIGENIX INC, H## 2018 SYNTIRON LLC Tetraphase Pharmaceuticals Inc (Tetraphase) is a pharmaceutical company that discovers and develops antibiotic resistance medicines.

  • Antibiotic Resistance
  • Biotech
  • United States
  • Product Initiative
  • Pfenex Inc.